PE-VC Fund Investments
Aragen Life Sciences attracts Rs.300-Cr from Avendus Future Leaders Fund, SBI Life
Aragen Life Sciences (formerly GVK Biosciences), a Hyderabad-based contract research, development, and manufacturing organisation (CRDMO), has attracted INR 300 crore (in equal share) from Avendus Future Leaders Fund III and SBI Life Insurance in return for a minority stake of over 2.5%. The stake has been acquired through a secondary transaction from the Reddy Investment Trust, which is associated with the GVK Group.
Between Nov 2007 and Jan 2025, Aragen Life Sciences had raised about USD 497 M from Quadria, Goldman Sachs, ChrysCapital and Peak XV Partners.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
